Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M330Revenue (TTM) $M19.4Net Margin (%)-369.6Altman Z-Score4.0
Enterprise Value $M191EPS (TTM) $-1.0Operating Margin %-374.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score-0.4Pre-tax Margin (%)-369.7Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %0.9Quick Ratio11.3Cash flow > EarningsY
Price/Sales16.95-y EBITDA Growth Rate %9.4Current Ratio11.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-39.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-44.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M70.9ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SGMO

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

SGMO is held by these investors:



SGMO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANPHIER EDWARD O IIPresident & CEO 2015-07-15Sell25,000$10.43-61.17view
Wolff Henry WardExec VP & CFO 2015-07-13Sell12,000$10-59.5view
LANPHIER EDWARD O IIPresident & CEO 2015-06-15Sell25,000$11.08-63.45view
Wolff Henry WardExec VP & CFO 2015-06-10Sell12,000$12.21-66.83view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-06-05Sell15,000$12.29-67.05view
RINGO WILLIAM RDirector 2015-06-03Sell2,200$12.44-67.44view
Gregory Philip DSVP of Research & CSO 2015-06-01Sell15,000$12.39-67.31view
LANPHIER EDWARD O IIPresident & CEO 2015-05-15Sell25,000$11.51-64.81view
Wolff Henry WardExec VP & CFO 2015-05-11Sell12,000$13.25-69.43view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-05-05Sell15,000$12.29-67.05view

Quarterly/Annual Reports about SGMO:

News about SGMO:

Articles On GuruFocus.com
Biogen or Bluebird: Which Will Lead in SCD? Apr 30 2015 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 03 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 05 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 06 2009 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 03 2009 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2009 

More From Other Websites
7:33 am Sangamo Therapeutics announces the presentation of new human in vitro and animal model data... Mar 29 2017
Sangamo Therapeutics Announces Presentation of New Data Demonstrating Significant Reduction of Tau... Mar 29 2017
ETFs with exposure to Sangamo Therapeutics, Inc. : March 27, 2017 Mar 27 2017
Sangamo Therapeutics, Inc. :SGMO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Mar 21 2017
SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 20 2017
Sangamo Therapeutics, Inc. :SGMO-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Mar 14 2017
SANGAMO THERAPEUTICS, INC Financials Mar 07 2017
Sangamo Therapeutics Announces Presentation At The Cowen And Company 37th Annual Health Care... Mar 01 2017
Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-913 Genome Editing... Mar 01 2017
Sangamo reports 4Q loss Feb 28 2017
Sangamo reports 4Q loss Feb 28 2017
Q4 2016 Sangamo Therapeutics Inc Earnings Release - Before Market Open Feb 28 2017
SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Change... Feb 28 2017
Sangamo Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results Feb 28 2017
Sangamo Therapeutics Announces Chief Financial Officer Succession Feb 27 2017
Sangamo Therapeutics Receives Rare Pediatric Disease Designation From FDA For SB-318 In Vivo Genome... Feb 27 2017
SANGAMO THERAPEUTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 24 2017
Sangamo Therapeutics Announces Fourth Quarter And Full Year 2016 Conference Call And Webcast Feb 21 2017
Sangamo Therapeutics Announces Upcoming Presentations At The 13th Annual WORLDSymposium™ Meeting Feb 08 2017
ETFs with exposure to Sangamo Therapeutics, Inc. : January 20, 2017 Jan 20 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)